G-code: Procedures and professional services (temporary) Procedures and professional services (temporary)
2,011 codes
Billing context
G-codes are temporary codes for professional services and procedures that would otherwise be coded in CPT.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| G2096 | Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given | — | Jan 1, 2020 | Active |
| G2097 | Episodes where the patient had a competing diagnosis on or within three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis, infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti) | — | Jan 1, 2020 | Active |
| G2098 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2099 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2100 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2101 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2102 | Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2103 | Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2104 | Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2105 | Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period | — | Jan 1, 2020 | Active |
| G2106 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2107 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2108 | Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2023 |
| G2109 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2023 |
| G2110 | Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2023 |
| G2112 | Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months | — | Jan 1, 2020 | Active |
| G2113 | Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity | — | Jan 1, 2020 | Active |
| G2114 | Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2115 | Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2116 | Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2117 | Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2118 | Patients 81 years of age and older with at least one claim/encounter for frailty during the measurement period | — | Jan 1, 2020 | Active |
| G2119 | Within the past 2 years, calcium and/or vitamin d optimization has been ordered or performed | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2120 | Within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performed | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2121 | Depression, anxiety, apathy, and psychosis assessed | — | Jan 1, 2020 | Active |
| G2122 | Depression, anxiety, apathy, and psychosis not assessed | — | Jan 1, 2020 | Active |
| G2123 | Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2124 | Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2125 | Patients 81 years of age and older with at least one claim/encounter for frailty during the six months prior to the measurement period through december 31 of the measurement period | — | Jan 1, 2020 | Active |
| G2126 | Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2127 | Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Active |
| G2128 | Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period) | — | Jan 1, 2020 | Active |
| G2129 | Procedure-related bp's not taken during an outpatient visit. examples include same day surgery, ambulatory service center, g.i. lab, dialysis, infusion center, chemotherapy | — | Jan 1, 2020 | Active |
| G2130 | Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2131 | Patients 81 years and older with a diagnosis of frailty | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2132 | Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2133 | Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2134 | Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2135 | Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2136 | Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater | — | Jan 1, 2020 | Active |
| G2137 | Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points | — | Jan 1, 2020 | Active |
| G2138 | Back pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater | — | Jan 1, 2020 | Active |
| G2139 | Back pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points | — | Jan 1, 2020 | Active |
| G2140 | Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater | — | Jan 1, 2020 | Active |
| G2141 | Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points | — | Jan 1, 2020 | Active |
| G2142 | Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 30 points or greater | — | Jan 1, 2020 | Active |
| G2143 | Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of less than 30 points | — | Jan 1, 2020 | Active |
| G2144 | Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6-20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6-20 weeks) postoperatively demonstrated an improvement of 30 points or greater | — | Jan 1, 2020 | Active |
| G2145 | Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of less than 30 points | — | Jan 1, 2020 | Active |
| G2146 | Leg pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater | — | Jan 1, 2020 | Active |
| G2147 | Leg pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points | — | Jan 1, 2020 | Active |
| G2148 | Multimodal pain management was used | — | Jan 1, 2020 | Active |
| G2149 | Documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s)) | — | Jan 1, 2020 | Active |
| G2150 | Multimodal pain management was not used | — | Jan 1, 2020 | Active |
| G2151 | Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care | — | Jan 1, 2020 | Active |
| G2152 | Residual score for the neck impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0) | — | Jan 1, 2020 | Active |
| G2153 | In hospice or using hospice services during the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2154 | Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2155 | Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2156 | Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2157 | Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2158 | Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2159 | Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2160 | Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2161 | Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2162 | Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2163 | Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2164 | Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2165 | Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2166 | Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason | — | Jan 1, 2020 | Ended Dec 31, 2020 |
| G2167 | Residual score for the neck impairment successfully calculated and the score was less than zero (< 0) | — | Jan 1, 2020 | Active |
| G2168 | Services performed by a physical therapist assistant in the home health setting in the delivery of a safe and effective physical therapy maintenance program, each 15 minutes | — | Jan 1, 2020 | Active |
| G2169 | Services performed by an occupational therapist assistant in the home health setting in the delivery of a safe and effective occupational therapy maintenance program, each 15 minutes | — | Jan 1, 2020 | Active |
| G2170 | Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed | — | Jul 1, 2020 | Ended Dec 31, 2022 |
| G2171 | Percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performed | — | Jul 1, 2020 | Ended Dec 31, 2022 |
| G2172 | All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project | — | Apr 1, 2021 | Active |
| G2173 | Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease) | — | Jan 1, 2021 | Active |
| G2174 | Uri episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date | — | Jan 1, 2021 | Active |
| G2175 | Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease) | — | Jan 1, 2021 | Active |
| G2176 | Outpatient, ed, or observation visits that result in an inpatient admission | — | Jan 1, 2021 | Active |
| G2177 | Acute bronchitis/bronchiolitis episodes when the patient had a new or refill prescription of antibiotics (table 1) in the 30 days prior to the episode date | — | Jan 1, 2021 | Active |
| G2178 | Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation | — | Jan 1, 2021 | Active |
| G2179 | Clinician documented that patient had medical reason for not performing lower extremity neurological exam | — | Jan 1, 2021 | Active |
| G2180 | Clinician documented that patient was not an eligible candidate for evaluation of footwear as patient is bilateral lower extremity amputee | — | Jan 1, 2021 | Active |
| G2181 | Bmi not documented due to medical reason or patient refusal of height or weight measurement | — | Jan 1, 2021 | Active |
| G2182 | Patient receiving first-time biologic and/or immune response modifier therapy | — | Jan 1, 2021 | Active |
| G2183 | Documentation patient unable to communicate and informant not available | — | Jan 1, 2021 | Active |
| G2184 | Patient does not have a caregiver | — | Jan 1, 2021 | Active |
| G2185 | Documentation caregiver is trained and certified in dementia care | — | Jan 1, 2021 | Active |
| G2186 | Patient /caregiver dyad has been referred to appropriate resources and connection to those resources is confirmed | — | Jan 1, 2021 | Active |
| G2187 | Patients with clinical indications for imaging of the head: head trauma | — | Jan 1, 2021 | Active |
| G2188 | Patients with clinical indications for imaging of the head: new or change in headache above 50 years of age | — | Jan 1, 2021 | Active |
| G2189 | Patients with clinical indications for imaging of the head: abnormal neurologic exam | — | Jan 1, 2021 | Active |
| G2190 | Patients with clinical indications for imaging of the head: headache radiating to the neck | — | Jan 1, 2021 | Active |
| G2191 | Patients with clinical indications for imaging of the head: positional headaches | — | Jan 1, 2021 | Active |
| G2192 | Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age | — | Jan 1, 2021 | Active |
| G2193 | Patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age) | — | Jan 1, 2021 | Active |
| G2194 | Patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior | — | Jan 1, 2021 | Active |
| G2195 | Patients with clinical indications for imaging of the head: occipital headache in children | — | Jan 1, 2021 | Active |
| G2196 | Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | — | Jan 1, 2021 | Active |